SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX)

CUSIP: 85205L107

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock, par value $.0001 per share
Shares outstanding
75,607,738
Total 13F shares
49,432,959
Share change
+4,000,775
Total reported value
$2,790,521,874
Put/Call ratio
93%
Price per share
$56.44
Number of holders
131
Value change
+$222,890,732
Number of buys
62
Number of sells
64

Quarterly Holders Quick Answers

What is CUSIP 85205L107?
CUSIP 85205L107 identifies SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) as of Q1 2022

As of 31 Mar 2022, SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) was held by 131 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 49,432,959 shares. The largest 10 holders included FMR LLC, ORBIMED ADVISORS LLC, Bain Capital Life Sciences Investors, LLC, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, BlackRock Inc., BOXER CAPITAL, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., DRIEHAUS CAPITAL MANAGEMENT LLC, and BANK OF AMERICA CORP /DE/. This page lists 131 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.